• CPL Completes Successful Virtual Health Canada Audit contractpharma
    June 04, 2021
    The CDMO created a virtual tour of its facilities in response to the pandemic.
  • Argonaut Expands Lyophilization Facility contractpharma
    May 24, 2021
    ​Argonaut Manufacturing Services, a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, is expanding its cGMP facilities in the Greater San Diego area of Carlsbad, CA.
  • Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center contractpharma
    May 21, 2021
    Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.
  • Cambrex Expands Analytical Services Capabilities contractpharma
    May 12, 2021
    Cambrex has expanded its cGMP analytical testing capabilities at its site in Longmont, CO. Existing space at the site has been repurposed with cutting edge technologies and doubles the footprint of the laboratory operations.
  • Richter-Helm Triples cGMP Production Capacity contractpharma
    May 08, 2021
    ​Richter-Helm BioLogics GmbH & Co. KG, a German CDMO, began construction for an expansion at its cGMP manufacturing facility in Bovenau, Germany.
  • Grand River Aseptic Manufacturing Earns Facility of the Year Award contractpharma
    April 30, 2021
    Grand River Aseptic Manufacturing, a leading injectable contract development and manufacturing organization (CDMO), was awarded the 2021 Facility of the Year Award for Special Recognition of Operational Agility: COVID-19 by the International Society ...
  • Catalent Biologics Completes Madison Expansion contractpharma
    April 14, 2021
    ​Catalent has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, WI, and began work on customer programs.
  • Anvisa says Covaxin producing facility does not meet CGMP standards expresspharma
    April 01, 2021
    The Brazilian health regulator Anvisa has denied permission to import Bharat Biotech’s COVID-19 vaccine Covaxin into the country after its authorities found that the plant in which the vaccine is being made did not meet the Current Good Manufacturing ...
  • Altasciences Doubles Size of PA CDMO Facility contractpharma
    March 11, 2021
    The additional 35,000-sq.-ft. building in Philadelphia will include warehouse and cGMP manufacturing suites.
  • Cascade Chemistry Initiates Expansion of cGMP Manufacturing Capacity americanpharmaceuticalreview
    February 23, 2021
    Cascade Chemistry announced initiation of construction of new facilities designed to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).
PharmaSources Customer Service